Exploratory Pilot Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis
K
Kathy Miller, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
This study will explore the biologic activity of guanabenz in reducing bone turn over in solid tumor patients with bone metastasis.
Description
The purpose of this study is to evaluate the biologic effect of guanabenz on bone turn over markers in patients with solid tumors and bone metastasis.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
bone cancers
-
Age: Between 18 Years - 100 Years
-
Gender: All
Updated on
23 Apr 2024.
Study ID: 1502722741 (IUCRO-0506)
